Pricing
Login
Home
Charts
Search
Watchlist
Products

Brooks Laboratories Ltd

BROOKS
₹67.20-0.15%20 Nov 2026
Reports
Pharma Formulations

Brooks Laboratories Ltd

BROOKS
₹67.20
-0.15%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹198Cr
Close
Close Price
₹67.20
Industry
Industry
Pharma Formulations
PE
Price To Earnings
2.72
PS
Price To Sales
2.51
Revenue
Revenue
₹79Cr
Rev Gr TTM
Revenue Growth TTM
-14.88%
PAT Gr TTM
PAT Growth TTM
421.40%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
221818212123262317202319
Growth YoY
Revenue Growth YoY%
42.240.514.2-14.5-5.731.642.312.8-19.3-13.3-10.0-17.9
Expenses
ExpensesCr
211718191922222116202119
Operating Profit
Operating ProfitCr
100222331120
OPM
OPM%
5.02.11.67.37.76.712.210.84.43.48.11.7
Other Income
Other IncomeCr
-4-9-2-5-3-27651-373
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-4-10-2-4-2-110862-273
Tax
TaxCr
000000000005
PAT
PATCr
-4-10-2-4-2-110862-268
Growth YoY
PAT Growth YoY%
59.1-124.046.1-141.545.184.8497.5301.5358.2204.1-118.7747.2
NPM
NPM%
-17.8-54.2-13.4-19.1-10.4-6.337.534.033.27.5-7.8351.2
EPS
EPS₹
-1.5-3.8-0.9-1.5-0.8-0.53.32.71.90.5-0.622.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
221818212123262317202319
Growth YoY
Revenue Growth YoY%
42.240.514.2-14.5-5.731.642.312.8-19.3-13.3-10.0-17.9
Expenses
ExpensesCr
211718191922222116202119
Operating Profit
Operating ProfitCr
100222331120
OPM
OPM%
5.02.11.67.37.76.712.210.84.43.48.11.7
Other Income
Other IncomeCr
-4-9-2-5-3-27651-373
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-4-10-2-4-2-110862-273
Tax
TaxCr
000000000005
PAT
PATCr
-4-10-2-4-2-110862-268
Growth YoY
PAT Growth YoY%
59.1-124.046.1-141.545.184.8497.5301.5358.2204.1-118.7747.2
NPM
NPM%
-17.8-54.2-13.4-19.1-10.4-6.337.534.033.27.5-7.8351.2
EPS
EPS₹
-1.5-3.8-0.9-1.5-0.8-0.53.32.71.90.5-0.622.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
77916379838679
Growth
Revenue Growth%
18.0-30.725.83.93.9-14.9
Expenses
ExpensesCr
771059076787975
Operating Profit
Operating ProfitCr
1-14-263574
OPM
OPM%
0.7-15.6-41.84.16.08.24.6
Other Income
Other IncomeCr
11-3-20-122077
Interest Expense
Interest ExpenseCr
3321111
Depreciation
DepreciationCr
7772222
PBT
PBTCr
-9-24-38-20-102578
Tax
TaxCr
10-5-70005
PAT
PATCr
-19-19-31-20-102573
Growth
PAT Growth%
0.3-60.836.949.1346.6421.4
NPM
NPM%
-25.1-21.2-49.1-24.6-12.128.792.2
EPS
EPS₹
-6.3-7.7-12.4-7.7-3.78.324.7
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
77916379838679
Growth
Revenue Growth%
18.0-30.725.83.93.9-14.9
Expenses
ExpensesCr
771059076787975
Operating Profit
Operating ProfitCr
1-14-263574
OPM
OPM%
0.7-15.6-41.84.16.08.24.6
Other Income
Other IncomeCr
11-3-20-122077
Interest Expense
Interest ExpenseCr
3321111
Depreciation
DepreciationCr
7772222
PBT
PBTCr
-9-24-38-20-102578
Tax
TaxCr
10-5-70005
PAT
PATCr
-19-19-31-20-102573
Growth
PAT Growth%
0.3-60.836.949.1346.6421.4
NPM
NPM%
-25.1-21.2-49.1-24.6-12.128.792.2
EPS
EPS₹
-6.3-7.7-12.4-7.7-3.78.324.7
Sales CAGR
1 Year4%
3 Years11%
5 Years2%
TTM-15%
EBITDA CAGR
1 Year43%
3 Years-
5 Years68%
TTM-59%
PAT CAGR
1 Year-
3 Years-
5 Years-
TTM421%
Avg. ROCE
1 Year19%
3 Years-5%
5 Years-16%
TTM41%
CFO / EBITDA
1 Year132%
3 Years14%
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
25252526292929
Reserves
ReservesCr
546349396993159
Current Liabilities
Current LiabilitiesCr
64493323232225
Non Current Liabilities
Non Current LiabilitiesCr
191332344
Total Liabilities
Total LiabilitiesCr
16219611090124148218
Current Assets
Current AssetsCr
476128313437101
Non Current Assets
Non Current AssetsCr
115135825990111116
Total Assets
Total AssetsCr
16219611090124148218
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
25252526292929
Reserves
ReservesCr
546349396993159
Current Liabilities
Current LiabilitiesCr
64493323232225
Non Current Liabilities
Non Current LiabilitiesCr
191332344
Total Liabilities
Total LiabilitiesCr
16219611090124148218
Current Assets
Current AssetsCr
476128313437101
Non Current Assets
Non Current AssetsCr
115135825990111116
Total Assets
Total AssetsCr
16219611090124148218

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4-37-14-1039
Investing Cash Flow
Investing Cash FlowCr
-5-2500-45-3
Financing Cash Flow
Financing Cash FlowCr
1641110420
Net Cash Flow
Net Cash FlowCr
02-3007
Free Cash Flow
Free Cash FlowCr
-1-58-15-1026
CFO To PAT
CFO To PAT%
-23.0193.946.750.0-26.437.8
CFO To EBITDA
CFO To EBITDA%
856.0262.754.9-301.153.2131.6
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4-37-14-1039
Investing Cash Flow
Investing Cash FlowCr
-5-2500-45-3
Financing Cash Flow
Financing Cash FlowCr
1641110420
Net Cash Flow
Net Cash FlowCr
02-3007
Free Cash Flow
Free Cash FlowCr
-1-58-15-1026
CFO To PAT
CFO To PAT%
-23.0193.946.750.0-26.437.8
CFO To EBITDA
CFO To EBITDA%
856.0262.754.9-301.153.2131.6

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
154179155244317110198
Price To Earnings
Price To Earnings
4.52.7
Price To Sales
Price To Sales
2.02.02.53.13.81.32.5
Price To Book
Price To Book
1.92.02.13.73.20.91.1
EV To EBITDA
EV To EBITDA
351.7-14.1-6.176.365.515.839.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
28.516.93.123.228.133.633.6
OPM
OPM%
0.7-15.6-41.84.16.08.24.6
NPM
NPM%
-25.1-21.2-49.1-24.6-12.128.792.2
ROCE
ROCE%
-5.3-18.4-45.0-26.3-8.319.440.7
ROE
ROE%
-24.5-22.1-42.0-29.9-10.220.038.6
ROA
ROA%
-11.9-9.9-28.3-21.7-8.116.633.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
154179155244317110198
Price To Earnings
Price To Earnings
4.52.7
Price To Sales
Price To Sales
2.02.02.53.13.81.32.5
Price To Book
Price To Book
1.92.02.13.73.20.91.1
EV To EBITDA
EV To EBITDA
351.7-14.1-6.176.365.515.839.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
28.516.93.123.228.133.633.6
OPM
OPM%
0.7-15.6-41.84.16.08.24.6
NPM
NPM%
-25.1-21.2-49.1-24.6-12.128.792.2
ROCE
ROCE%
-5.3-18.4-45.0-26.3-8.319.440.7
ROE
ROE%
-24.5-22.1-42.0-29.9-10.220.038.6
ROA
ROA%
-11.9-9.9-28.3-21.7-8.116.633.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr232205202198177154151
Close PriceClose₹320.00167.10160.7067.20161.7018.5492.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE28.9320.600.282.7233.4111.249.47
Price To SalesPS4.732.433.122.516.980.591.27
RevenueRevenueCr4984657925259118
Revenue Growth TTMRev Gr TTM%96.6%22.5%-14.9%3.4%50.8%7.5%
PAT Growth TTMPAT Gr TTM%83.2%33.6%421.4%-29.6%20.1%16.4%
Market CapitalizationMkt CapCr232205202198177154151
Close PriceClose₹320.00167.10160.7067.20161.7018.5492.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE28.9320.600.282.7233.4111.249.47
Price To SalesPS4.732.433.122.516.980.591.27
RevenueRevenueCr4984657925259118
Revenue Growth TTMRev Gr TTM%96.6%22.5%-14.9%3.4%50.8%7.5%
PAT Growth TTMPAT Gr TTM%83.2%33.6%421.4%-29.6%20.1%16.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews